Recreational Use of Phosphodiesterase 5 Inhibitors and Its Associated Factors among Undergraduate Male Students in an Ethiopian University: A Cross-Sectional Study

다국어 초록 (Multilingual Abstract)

Purpose: To assess the prevalence of phosphodiesterase 5 (PDE5) inhibitor use and associated factors among University of Gondar undergraduate students.Materials and Methods: An institution-based, cross-sectional study, using a survey questionnaire, was conducted from October to December 2015 to assess PDE5 inhibitor use and associated factors among male students at the University of Gondar. A Self-Esteem and Relationship questionnaire (14 items), an International Index of Erectile Function questionnaire (15 items) and a questionnaire on PDE5 inhibitor use (14 items) were included in the survey.Results: Across all respondents (age, 21.9±1.88 years), more than half (55.7%, n=233) had heard about PDE5 inhibitors, but only 23 men (5.5%) reported trying a PDE5 inhibitor drug at least once. Older students were more likely to use PDE5 inhibitors compared to younger students (adjusted odds ratio [AOR], 1.40; 95% confidence interval [CI], 1.109∼1.768). Those students who were smokers were 5.15 times more likely to use PDE5 inhibitors as compared to their non-smoking counterparts (AOR, 5.15; 95% CI, 2.096∼12.687). In addition, multivariate logistic regression showed that being in a relationship, alcohol use, greater number of cigarettes smoked per day, and more sexual partners were significantly associated with PDE5 inhibitor use.Conclusions: The prevalence of PDE5 inhibitor use among undergraduate students was 5.5%. Cigarette smoking and other substance use, older age, and greater number of sexual partners were significantly associated factors for PDE5 inhibitor use. These findings suggest that restricting access to PDE5 inhibitor drugs is essential to curtailing misuse among university students.

참고문헌 (Reference)

1 Freitas VM, "Use of phosphodiesterase-5 inhibitors by college students" 42 : 965-967, 2008

2 Shindel AW, "The sexual lives of medical students: a single institution survey" 5 : 796-803, 2008

3 Ayta IA, "The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences" 84 : 50-56, 1999

4 Rosen RC, "The international index of erectile function (IIEF):a multidimensional scale for assessment of erectile dysfunction" 49 : 822-830, 1997

5 Laumann EO, "Sexual dysfunction in the United States: prevalence and predictors" 281 : 537-544, 1999

6 Bechara A, "Recreational use of phosphodiesterase type 5 inhibitors by healthy young men" 7 : 3736-3742, 2010

7 Harte CB, "Recreational use of erectile dysfunction medications in undergraduate men in the United States:characteristics and associated risk factors" 40 : 597-606, 2011

8 Santtila P, "Recreational use of erectile dysfunction medication may decrease confidence in ability to gain and hold erections in young males" 19 : 591-596, 2007

9 Korkes F, "Recreational use of PDE5 inhibitors by young healthy men: recognizing this issue among medical students" 5 : 2414-2418, 2008

10 Gebreslassie M, "Psychoactive substances use and associated factors among Axum University students, Axum Town, North Ethiopia" 13 : 693-, 2013

11 Kimura M, "Profiling characteristics of men who use phosphodiesterase type 5 inhibitors based on obtaining patterns: data from the nationwide Japanese population" 9 : 1649-1658, 2012

12 Hornung M, "Prevalence of universities that make use of medicines for erectile dysfunction treatment" 13 : 27-32, 2012

13 Lowe G, "Phosphodiesterase type 5 inhibitor abuse: a critical review" 4 : 87-94, 2011

14 Dingeta T, "Patterns of sexual risk behavior among undergraduate university students in Ethiopia: a cross-sectional study" 12 : 33-, 2012

15 Duryea DG, "Nonmedical use of prescription drugs by college students with minority sexual orientations" 29 : 147-159, 2015

16 Mitchell KR, "Medicated sex in Britain: evidence from the third National Survey of Sexual Attitudes and Lifestyles" 92 : 32-38, 2016

17 Mossie TB, "Magnitude of psychoactive substance abuse among university students, Adigrat, North Ethiopia: cross-sectional study" 18 : 281-, 2015

18 NIH Consensus Conference, "Impotence. NIH consensus development panel on impotence" 270 : 83-90, 1993

19 Mulhall J, "Importance of and satisfaction with sex among men and women worldwide: results of the global better sex survey" 5 : 788-795, 2008

20 Musacchio NS, "Erectile dysfunction and viagra use: what's up with college-age males?" 39 : 452-454, 2006

21 Cappelleri JC, "Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction" 16 : 30-38, 2004

22 Yang Y, "Association between dosage frequency and the treatment outcomes of sildenafil in young and middle-aged men with erectile dysfunction: a chinese, multicenter, observational study" 86 : 62-67, 2015

23 Li J, "Alcohol and drug use during unprotected anal intercourse among gay and bisexual men in Scotland:what are the implications for HIV prevention?" 90 : 125-132, 2014

24 Campbell N, "Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors" 10 : 1842-1849, 2013

25 Both R, "A matter of sexual confidence: young men's nonprescription use of Viagra in Addis Ababa, Ethiopia" 18 : 495-508, 2016